ClinVar Miner

Submissions for variant NM_152906.7(TANGO2):c.634C>T (p.Gln212Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003671895 SCV004385366 pathogenic not provided 2024-01-19 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln212*) in the TANGO2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TANGO2 are known to be pathogenic (PMID: 26805781, 26805782). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TANGO2-related conditions. For these reasons, this variant has been classified as Pathogenic.
Neuberg Centre For Genomic Medicine, NCGM RCV004764859 SCV005374831 likely pathogenic Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome criteria provided, single submitter clinical testing The observed stop gained c.634C>T (p.Gln212Ter) variant in TANGO2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Gln212Ter variant is absent in gnomAD Exomes. This variant has not been submitted to the ClinVar database. Computational evidence (MutationTaster - Disease causing) predicts damaging effect on protein structure and function for this variant. The reference amino acid of p.Gln212Ter in TANGO2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This sequence change creates a premature translational stop signal (p.Gln212Ter) in the TANGO2 gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants in TANGO2 gene have been previously reported to be disease causing (Kremer et al., 2016). However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.